2013 BioPharmAsia ”Asia’s 20 Most Promising Biotech Companies”

2013 Phase II/III Clinical Trial Approval for Icaritin

2011 Key Technical Research Project of Haidian District, Beijing

2011 Beijing High-Tech Enterprises

2011 Top 10 Zhongguancun VC Cases

2010 Beijing Intellectual Property Pilot Enterprises

2009 Member Enterprises of Beijing Zhongguancun High-Tech Enterprises Association

2009 Member of China Medicinal Biotech Association

2008 ChinaBio VC Congress “Chinese Most Promising Biotech Company”

2008 Member Enterprises of China Chinese Medicine Institute

2008 Board Member of Pharmaceutical Biotechnology Union

2008 Three World-class Scientists of Breast Cancer Research Joined Shenogen Scientific Advisory Board

    Awards & Recognitions